6:25 PM
 | 
Dec 12, 2012
 |  BC Extra  |  Financial News

Charles River falls on 2013 guidance

Charles River Laboratories International Inc. (NYSE:CRL) fell $3.65 to $35.65 on Wednesday after introducing 2013 guidance that was below the Street's estimates. The...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >